» Articles » PMID: 38412547

Does Paging Clinicians About Tick-Borne Disease Serological Results Impact Clinical Care? A Retrospective Analysis of 70 Cases in North Carolina

Overview
Specialty Tropical Medicine
Date 2024 Feb 27
PMID 38412547
Authors
Affiliations
Soon will be listed here.
Abstract

Delayed treatment of Rocky Mountain spotted fever is associated with increased morbidity and mortality. Because the diagnosis cannot be established from a single serological test, guidelines recommend empirical antibiotic initiation in suspect patients. We evaluated a policy used by UNC Health of paging clinicians when acute testing for Rickettsia returned with a titer ≥1:256. Our objective was to assess the potential effect of paging on routine treatment practices. Notably, we found that a high proportion of cases (N = 28, 40%) were not prescribed antibiotics until the results were available. The vast majority of these cases did not have evidence of compatible symptoms or disease progression. These findings suggest that paging may have prompted unnecessary treatment. Overall, the policy, which has now been discontinued, appears to have had limited benefit. Efforts are urgently needed to improve adherence to testing and treatment guidelines.

Citing Articles

Contribution of Limited Molecular Testing to Low Ehrlichiosis Diagnosis in High Incidence Area, North Carolina, USA.

Siegler A, Ursery L, Giandomenico D, Miller M, Salzer J, Barbarin A Emerg Infect Dis. 2025; 31(2):281-287.

PMID: 39983688 PMC: 11845130. DOI: 10.3201/eid3102.240281.

References
1.
Biggs H, Behravesh C, Bradley K, Dahlgren F, Drexler N, Dumler J . Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep. 2016; 65(2):1-44. DOI: 10.15585/mmwr.rr6502a1. View

2.
Kirkland K, WILKINSON W, Sexton D . Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995; 20(5):1118-21. DOI: 10.1093/clinids/20.5.1118. View

3.
Dalton M, Clarke M, Holman R, Krebs J, Fishbein D, Olson J . National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 1995; 52(5):405-13. DOI: 10.4269/ajtmh.1995.52.405. View

4.
Straily A, Stuck S, Singleton J, Brennan S, Marcum S, Condit M . Antibody Titers Reactive With Rickettsia rickettsii in Blood Donors and Implications for Surveillance of Spotted Fever Rickettsiosis in the United States. J Infect Dis. 2019; 221(8):1371-1378. DOI: 10.1093/infdis/jiz316. View

5.
Binder A, Armstrong P . Patient characteristics, treatment patterns, and outcomes of Rickettsial diseases among a commercially insured population in the United States, 2005-2017. Sci Rep. 2021; 11(1):18382. PMC: 8443668. DOI: 10.1038/s41598-021-96463-9. View